Broecker Notes Recent Company Milestones

Apex Therapeutics CEO, David Broecker, presented at the 2015 BIO International Convention in Philadelphia. June 16. He provided an update on the achievement of corporate milestones and outline the plans for the development of APX3330 for the treatment of pancreatic cancer. The company recently achieved several company milestones including: Issued patent US#9,040,505 on a method for inhibiting pancreatic cancer through the administration of APX3330.  This … Read more…